Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 85716 entries
Sorted by: Best Match Show Resources per page
Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report.

JCO precision oncology

He X, Jiao XD, Liu K, Qin BD, Wu Y, Ling Y, Liu J, Xu AQ, Song K, Zang YS.
PMID: 34036227
JCO Precis Oncol. 2021 May 03;5. doi: 10.1200/PO.20.00534. eCollection 2021.

No abstract available.

Cite
He X, Jiao XD, Liu K, et al. Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00534.
He, X., Jiao, X. D., Liu, K., Qin, B. D., Wu, Y., Ling, Y., Liu, J., Xu, A. Q., Song, K., & Zang, Y. S. (2021). Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00534
He, Xi, et al. "Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00534
He X, Jiao XD, Liu K, Qin BD, Wu Y, Ling Y, Liu J, Xu AQ, Song K, Zang YS. Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report. JCO Precis Oncol. 2021 May 03;5. doi: 10.1200/PO.20.00534. eCollection 2021. PMID: 34036227; PMCID: PMC8140796.
Copy Download .nbib Format: NLM
Dietary Supplementation of Inulin Ameliorates Subclinical Mastitis via Regulation of Rumen Microbial Community and Metabolites in Dairy Cows.

Microbiology spectrum

Wang Y, Nan X, Zhao Y, Jiang L, Wang H, Zhang F, Hua D, Liu J, Yao J, Yang L, Luo Q, Xiong B.
PMID: 34494854
Microbiol Spectr. 2021 Oct 31;9(2):e0010521. doi: 10.1128/Spectrum.00105-21. Epub 2021 Sep 08.

Subclinical mastitis (SCM) is one of the highly infectious diseases in dairy cows with the characteristics of high incidence and nonvisible clinical symptoms. The gastrointestinal microbiota is closely related to mastitis. Inulin is a prebiotic fiber with functions in...

Cite
Wang Y, Nan X, Zhao Y, et al. Dietary Supplementation of Inulin Ameliorates Subclinical Mastitis via Regulation of Rumen Microbial Community and Metabolites in Dairy Cows. Microbiol Spectr. 2021;9(2):e0010521doi: 10.1128/Spectrum.00105-21.
Wang, Y., Nan, X., Zhao, Y., Jiang, L., Wang, H., Zhang, F., Hua, D., Liu, J., Yao, J., Yang, L., Luo, Q., & Xiong, B. (2021). Dietary Supplementation of Inulin Ameliorates Subclinical Mastitis via Regulation of Rumen Microbial Community and Metabolites in Dairy Cows. Microbiology spectrum, 9(2), e0010521. https://doi.org/10.1128/Spectrum.00105-21
Wang, Yue, et al. "Dietary Supplementation of Inulin Ameliorates Subclinical Mastitis via Regulation of Rumen Microbial Community and Metabolites in Dairy Cows." Microbiology spectrum vol. 9,2 (2021): e0010521. doi: https://doi.org/10.1128/Spectrum.00105-21
Wang Y, Nan X, Zhao Y, Jiang L, Wang H, Zhang F, Hua D, Liu J, Yao J, Yang L, Luo Q, Xiong B. Dietary Supplementation of Inulin Ameliorates Subclinical Mastitis via Regulation of Rumen Microbial Community and Metabolites in Dairy Cows. Microbiol Spectr. 2021 Oct 31;9(2):e0010521. doi: 10.1128/Spectrum.00105-21. Epub 2021 Sep 08. PMID: 34494854; PMCID: PMC8557905.
Copy Download .nbib Format: NLM
Gibberellic acid-induced fatty acid metabolism and ABC transporters promote astaxanthin production in Phaffia rhodozyma.

Journal of applied microbiology

Liu S, Yi H, Zhan H, Wang L, Wang J, Li Y, Liu B.
PMID: 34161638
J Appl Microbiol. 2022 Jan;132(1):390-400. doi: 10.1111/jam.15187. Epub 2021 Jul 13.

AIMS: Astaxanthin is an important natural antioxidant with various biological functions; however, the production of astaxanthin does not meet the requirements for industrialization. The aim of the present study was to identify an inducer that increases astaxanthin yield and...

Cite
Liu S, Yi H, Zhan H, et al. Gibberellic acid-induced fatty acid metabolism and ABC transporters promote astaxanthin production in Phaffia rhodozyma. J Appl Microbiol. 2021;132(1):390-400doi: 10.1111/jam.15187.
Liu, S., Yi, H., Zhan, H., Wang, L., Wang, J., Li, Y., & Liu, B. (2022). Gibberellic acid-induced fatty acid metabolism and ABC transporters promote astaxanthin production in Phaffia rhodozyma. Journal of applied microbiology, 132(1), 390-400. https://doi.org/10.1111/jam.15187
Liu, Sijiao, et al. "Gibberellic acid-induced fatty acid metabolism and ABC transporters promote astaxanthin production in Phaffia rhodozyma." Journal of applied microbiology vol. 132,1 (2022): 390-400. doi: https://doi.org/10.1111/jam.15187
Liu S, Yi H, Zhan H, Wang L, Wang J, Li Y, Liu B. Gibberellic acid-induced fatty acid metabolism and ABC transporters promote astaxanthin production in Phaffia rhodozyma. J Appl Microbiol. 2022 Jan;132(1):390-400. doi: 10.1111/jam.15187. Epub 2021 Jul 13. PMID: 34161638.
Copy Download .nbib Format: NLM
Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency.

Blood

Wang Y, Li W, Schulz VP, Zhao H, Qu X, Qi Q, Cheng Y, Guo X, Zhang S, Wei X, Liu D, Yazdanbakhsh K, Hillyer CD, Mohandas N, Chen L, Gallagher PG, An X.
PMID: 34036344
Blood. 2021 Oct 28;138(17):1615-1627. doi: 10.1182/blood.2020007401.

Histone deacetylases (HDACs) are a group of enzymes that catalyze the removal of acetyl groups from histone and nonhistone proteins. HDACs have been shown to have diverse functions in a wide range of biological processes. However, their roles in...

Cite
Wang Y, Li W, Schulz VP, et al. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood. 2021;138(17):1615-1627doi: 10.1182/blood.2020007401.
Wang, Y., Li, W., Schulz, V. P., Zhao, H., Qu, X., Qi, Q., Cheng, Y., Guo, X., Zhang, S., Wei, X., Liu, D., Yazdanbakhsh, K., Hillyer, C. D., Mohandas, N., Chen, L., Gallagher, P. G., & An, X. (2021). Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood, 138(17), 1615-1627. https://doi.org/10.1182/blood.2020007401
Wang, Yaomei, et al. "Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency." Blood vol. 138,17 (2021): 1615-1627. doi: https://doi.org/10.1182/blood.2020007401
Wang Y, Li W, Schulz VP, Zhao H, Qu X, Qi Q, Cheng Y, Guo X, Zhang S, Wei X, Liu D, Yazdanbakhsh K, Hillyer CD, Mohandas N, Chen L, Gallagher PG, An X. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood. 2021 Oct 28;138(17):1615-1627. doi: 10.1182/blood.2020007401. PMID: 34036344; PMCID: PMC8554652.
Copy Download .nbib Format: NLM
The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections.

International journal of general medicine

Zhu S, Zeng C, Zou Y, Hu Y, Tang C, Liu C.
PMID: 34729020
Int J Gen Med. 2021 Oct 24;14:7107-7113. doi: 10.2147/IJGM.S327958. eCollection 2021.

BACKGROUND: Bacterial, viral, and bacterial and viral co-infections generally lead to inflammatory-related diseases. The aim of this study is to assess the clinical diagnostic values of serum amyloid A (SAA), procalcitonin (PCT), C-reactive protein (CRP), and interleukin (IL)-6 in...

Cite
Zhu S, Zeng C, Zou Y, et al. The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections. Int J Gen Med. 2021;14:7107-7113doi: 10.2147/IJGM.S327958.
Zhu, S., Zeng, C., Zou, Y., Hu, Y., Tang, C., & Liu, C. (2021). The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections. International journal of general medicine, 147107-7113. https://doi.org/10.2147/IJGM.S327958
Zhu, Shunxin, et al. "The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections." International journal of general medicine vol. 14 (2021): 7107-7113. doi: https://doi.org/10.2147/IJGM.S327958
Zhu S, Zeng C, Zou Y, Hu Y, Tang C, Liu C. The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children with Bacterial, Viral, or Co-Infections. Int J Gen Med. 2021 Oct 24;14:7107-7113. doi: 10.2147/IJGM.S327958. eCollection 2021. PMID: 34729020; PMCID: PMC8554317.
Copy Download .nbib Format: NLM
Champion Position Analysis in Short Track Speed Skating Competitions From 2007 to 2019.

Frontiers in psychology

Sun L, Guo T, Liu F, Tao K.
PMID: 34950087
Front Psychol. 2021 Dec 07;12:760900. doi: 10.3389/fpsyg.2021.760900. eCollection 2021.

No abstract available.

Cite
Sun L, Guo T, Liu F, et al. Champion Position Analysis in Short Track Speed Skating Competitions From 2007 to 2019. Front Psychol. 2021;12:760900doi: 10.3389/fpsyg.2021.760900.
Sun, L., Guo, T., Liu, F., & Tao, K. (2021). Champion Position Analysis in Short Track Speed Skating Competitions From 2007 to 2019. Frontiers in psychology, 12760900. https://doi.org/10.3389/fpsyg.2021.760900
Sun, Lixin, et al. "Champion Position Analysis in Short Track Speed Skating Competitions From 2007 to 2019." Frontiers in psychology vol. 12 (2021): 760900. doi: https://doi.org/10.3389/fpsyg.2021.760900
Sun L, Guo T, Liu F, Tao K. Champion Position Analysis in Short Track Speed Skating Competitions From 2007 to 2019. Front Psychol. 2021 Dec 07;12:760900. doi: 10.3389/fpsyg.2021.760900. eCollection 2021. PMID: 34950087; PMCID: PMC8689186.
Copy Download .nbib Format: NLM
Editorial: Moving Beyond Non-informative Prior Distributions: Achieving the Full Potential of Bayesian Methods for Psychological Research.

Frontiers in psychology

Koenig C, Depaoli S, Liu H, van de Schoot R.
PMID: 34956030
Front Psychol. 2021 Dec 09;12:809719. doi: 10.3389/fpsyg.2021.809719. eCollection 2021.

No abstract available.

Cite
Koenig C, Depaoli S, Liu H, et al. Editorial: Moving Beyond Non-informative Prior Distributions: Achieving the Full Potential of Bayesian Methods for Psychological Research. Front Psychol. 2021;12:809719doi: 10.3389/fpsyg.2021.809719.
Koenig, C., Depaoli, S., Liu, H., & van de Schoot, R. (2021). Editorial: Moving Beyond Non-informative Prior Distributions: Achieving the Full Potential of Bayesian Methods for Psychological Research. Frontiers in psychology, 12809719. https://doi.org/10.3389/fpsyg.2021.809719
Koenig, Christoph, et al. "Editorial: Moving Beyond Non-informative Prior Distributions: Achieving the Full Potential of Bayesian Methods for Psychological Research." Frontiers in psychology vol. 12 (2021): 809719. doi: https://doi.org/10.3389/fpsyg.2021.809719
Koenig C, Depaoli S, Liu H, van de Schoot R. Editorial: Moving Beyond Non-informative Prior Distributions: Achieving the Full Potential of Bayesian Methods for Psychological Research. Front Psychol. 2021 Dec 09;12:809719. doi: 10.3389/fpsyg.2021.809719. eCollection 2021. PMID: 34956030; PMCID: PMC8695424.
Copy Download .nbib Format: NLM
Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers.

Aging

Chen Y, Ma C, Liu L, He J, Zhu C, Zheng F, Dai W, Hong X, Liu D, Tang D, Dai Y.
PMID: 34670873
Aging (Albany NY). 2021 Oct 20;13(20):23689-23701. doi: 10.18632/aging.203641. Epub 2021 Oct 20.

Rheumatoid arthritis (RA) is an autoimmune disease described by joint destruction, synovitis and pannus formation. The gut microbiota acts as an environmental factor that plays an important role in RA, but little research regarding the etiopathogenic mechanisms of the...

Cite
Chen Y, Ma C, Liu L, et al. Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers. Aging (Albany NY). 2021;13(20):23689-23701doi: 10.18632/aging.203641.
Chen, Y., Ma, C., Liu, L., He, J., Zhu, C., Zheng, F., Dai, W., Hong, X., Liu, D., Tang, D., & Dai, Y. (2021). Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers. Aging, 13(20), 23689-23701. https://doi.org/10.18632/aging.203641
Chen, Yumei, et al. "Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers." Aging vol. 13,20 (2021): 23689-23701. doi: https://doi.org/10.18632/aging.203641
Chen Y, Ma C, Liu L, He J, Zhu C, Zheng F, Dai W, Hong X, Liu D, Tang D, Dai Y. Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers. Aging (Albany NY). 2021 Oct 20;13(20):23689-23701. doi: 10.18632/aging.203641. Epub 2021 Oct 20. PMID: 34670873; PMCID: PMC8580343.
Copy Download .nbib Format: NLM
Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.

Frontiers in endocrinology

Luo Y, Zhang Z, Xiang L, Zhou B, Wang X, Lin Y, Ding X, Liu F, Lu Y, Peng Y.
PMID: 34950107
Front Endocrinol (Lausanne). 2021 Dec 07;12:780617. doi: 10.3389/fendo.2021.780617. eCollection 2021.

Improvements in living standards have led to non-alcoholic fatty liver disease (NAFLD), one of the most common chronic liver diseases worldwide. Recent studies have shown that N6-methyladenosine (m6A), a type of RNA modification, is strongly associated with many important...

Cite
Luo Y, Zhang Z, Xiang L, et al. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne). 2021;12:780617doi: 10.3389/fendo.2021.780617.
Luo, Y., Zhang, Z., Xiang, L., Zhou, B., Wang, X., Lin, Y., Ding, X., Liu, F., Lu, Y., & Peng, Y. (2021). Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. Frontiers in endocrinology, 12780617. https://doi.org/10.3389/fendo.2021.780617
Luo, Yunchen, et al. "Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease." Frontiers in endocrinology vol. 12 (2021): 780617. doi: https://doi.org/10.3389/fendo.2021.780617
Luo Y, Zhang Z, Xiang L, Zhou B, Wang X, Lin Y, Ding X, Liu F, Lu Y, Peng Y. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne). 2021 Dec 07;12:780617. doi: 10.3389/fendo.2021.780617. eCollection 2021. PMID: 34950107; PMCID: PMC8688819.
Copy Download .nbib Format: NLM
Boosting oxygen reduction activity and enhancing stability through structural transformation of layered lithium manganese oxide.

Nature communications

Zhong X, Oubla M, Wang X, Huang Y, Zeng H, Wang S, Liu K, Zhou J, He L, Zhong H, Alonso-Vante N, Wang CW, Wu WB, Lin HJ, Chen CT, Hu Z, Huang Y, Ma J.
PMID: 34035291
Nat Commun. 2021 May 25;12(1):3136. doi: 10.1038/s41467-021-23430-3.

Structural degradation in manganese oxides leads to unstable electrocatalytic activity during long-term cycles. Herein, we overcome this obstacle by using proton exchange on well-defined layered Li

Cite
Zhong X, Oubla M, Wang X, et al. Boosting oxygen reduction activity and enhancing stability through structural transformation of layered lithium manganese oxide. Nat Commun. 2021;12(1):3136doi: 10.1038/s41467-021-23430-3.
Zhong, X., Oubla, M., Wang, X., Huang, Y., Zeng, H., Wang, S., Liu, K., Zhou, J., He, L., Zhong, H., Alonso-Vante, N., Wang, C. W., Wu, W. B., Lin, H. J., Chen, C. T., Hu, Z., Huang, Y., & Ma, J. (2021). Boosting oxygen reduction activity and enhancing stability through structural transformation of layered lithium manganese oxide. Nature communications, 12(1), 3136. https://doi.org/10.1038/s41467-021-23430-3
Zhong, Xuepeng, et al. "Boosting oxygen reduction activity and enhancing stability through structural transformation of layered lithium manganese oxide." Nature communications vol. 12,1 (2021): 3136. doi: https://doi.org/10.1038/s41467-021-23430-3
Zhong X, Oubla M, Wang X, Huang Y, Zeng H, Wang S, Liu K, Zhou J, He L, Zhong H, Alonso-Vante N, Wang CW, Wu WB, Lin HJ, Chen CT, Hu Z, Huang Y, Ma J. Boosting oxygen reduction activity and enhancing stability through structural transformation of layered lithium manganese oxide. Nat Commun. 2021 May 25;12(1):3136. doi: 10.1038/s41467-021-23430-3. PMID: 34035291; PMCID: PMC8149866.
Copy Download .nbib Format: NLM
A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma.

Journal of oncology

Wang G, Zou H, Feng Y, Zhao W, Li K, Liu K, Zhang B, Zhu C.
PMID: 34950206
J Oncol. 2021 Dec 14;2021:1452801. doi: 10.1155/2021/1452801. eCollection 2021.

Hepatocellular carcinoma (HCC) is a common malignant tumor with high incidence and mortality rates. However, a reliable prognostic signature has not yet been confirmed. Thus, the purpose of the present study was to develop a biomarker with high specificity...

Cite
Wang G, Zou H, Feng Y, et al. A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma. J Oncol. 2021;2021:1452801doi: 10.1155/2021/1452801.
Wang, G., Zou, H., Feng, Y., Zhao, W., Li, K., Liu, K., Zhang, B., & Zhu, C. (2021). A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma. Journal of oncology, 20211452801. https://doi.org/10.1155/2021/1452801
Wang, Guangfeng, et al. "A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma." Journal of oncology vol. 2021 (2021): 1452801. doi: https://doi.org/10.1155/2021/1452801
Wang G, Zou H, Feng Y, Zhao W, Li K, Liu K, Zhang B, Zhu C. A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma. J Oncol. 2021 Dec 14;2021:1452801. doi: 10.1155/2021/1452801. eCollection 2021. PMID: 34950206; PMCID: PMC8691992.
Copy Download .nbib Format: NLM
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.

The EPMA journal

Lu M, Zhan H, Liu B, Li D, Li W, Chen X, Zhou X.
PMID: 34950253
EPMA J. 2021 Oct 21;12(4):589-604. doi: 10.1007/s13167-021-00259-w. eCollection 2021 Dec.

BACKGROUND: Bladder cancer (BC) is a commonly occurring malignant tumor of the urinary system, demonstrating high global morbidity and mortality rates. BC currently lacks widely accepted biomarkers and its predictive, preventive, and personalized medicine (PPPM) is still unsatisfactory. N6-methyladenosine...

Cite
Lu M, Zhan H, Liu B, et al. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. EPMA J. 2021;12(4):589-604doi: 10.1007/s13167-021-00259-w.
Lu, M., Zhan, H., Liu, B., Li, D., Li, W., Chen, X., & Zhou, X. (2021). N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. The EPMA journal, 12(4), 589-604. https://doi.org/10.1007/s13167-021-00259-w
Lu, Miaolong, et al. "N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer." The EPMA journal vol. 12,4 (2021): 589-604. doi: https://doi.org/10.1007/s13167-021-00259-w
Lu M, Zhan H, Liu B, Li D, Li W, Chen X, Zhou X. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. EPMA J. 2021 Oct 21;12(4):589-604. doi: 10.1007/s13167-021-00259-w. eCollection 2021 Dec. PMID: 34950253; PMCID: PMC8648947.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 85716 entries